🟢 Incyte Corporation is trading 5.08% up

INCY October 16, 2026

🟢 Incyte is trading 4.18% up in pre-market; no verified company-specific catalyst identified

INCY October 03, 2026

Incyte's IDO1 Inhibitor Fails to Boost T-Cell Response in Melanoma Trial

INCY September 22, 2026

🔴 Incyte is trading 27.09% down in after-hours trading with no clear catalyst identified

INCY September 22, 2026

🔴 Incyte is trading 22% down in pre-market with no clear company-specific catalyst identified

INCY September 14, 2026

Incyte Jumps 6% on Canadian Reimbursement Win — But Can a Single Province Move the Needle on a $5 Billion Revenue Machine?